Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perampanel Improves Cortical Myoclonus and Disability in Progressive Myoclonic Epilepsies: A Case Series and a Systematic Review of the Literature
Giovanni Assenza, Cristofaro Nocerino, Mario Tombini, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 24

Showing 24 citing articles:

The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
Fabio Perversi, Cinzia Costa, Angelo Labate, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 19
Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances
Vincent Zimmern, Berge A. Minassian
Genes (2024) Vol. 15, Iss. 2, pp. 171-171
Open Access | Times Cited: 7
Efficacy and tolerability of antiseizure drugs
Tahir Hakami
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 28
Late-onset myoclonic epilepsy in Down syndrome (LOMEDS) and efficacy of perampanel.
Nazaret Peláez Viña, Dennis Dunlop Bórquez, Esther Moral, et al.
Neurology Perspectives (2025), pp. 100184-100184
Open Access
Epilepsia mioclónica progresiva tardía asociada al síndrome de Down y papel terapéutico de perampanel
Nazaret Pelaez-Viñas, Dennis Dunlop Bórquez, Esther Moral, et al.
Neurología (2025)
Open Access
Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study
Norman Delanty, Rajiv Mohanraj, Rohit Shankar, et al.
Epilepsy Research (2024) Vol. 202, pp. 107339-107339
Open Access | Times Cited: 3
Perampanel enhances the cardiovagal tone and heart rate variability (HRV) in patients with drug-resistant temporal lobe epilepsy
Fedele Dono, Giacomo Evangelista, Stefano Consoli, et al.
Seizure (2022) Vol. 99, pp. 16-23
Closed Access | Times Cited: 14
ILAE Genetics Literacy series: Progressive myoclonus epilepsies
Jillian M. Cameron, Colin A. Ellis, Samuel F. Berkovic
Epileptic Disorders (2023) Vol. 25, Iss. 5, pp. 670-680
Open Access | Times Cited: 8
Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients’ data analysis
Clarissa Corniello, Fedele Dono, Giacomo Evangelista, et al.
Seizure (2023) Vol. 109, pp. 62-67
Open Access | Times Cited: 7
Myoclonus: an update
Betsy Thomas, Steven J. Frucht
Current Opinion in Neurology (2024) Vol. 37, Iss. 4, pp. 421-425
Closed Access | Times Cited: 2
Progressive myoclonic epilepsy as an expanding phenotype of NGLY1-associated congenital deglycosylation disorder: A case report and review of the literature
Yuri Sonoda, Atsushi Fujita, Michiko Torio, et al.
European Journal of Medical Genetics (2023) Vol. 67, pp. 104895-104895
Open Access | Times Cited: 5
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study
Angelo Pascarella, Sara Gasparini, Lucia Manzo, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 122797-122797
Open Access | Times Cited: 4
Clinical efficacy of low‐dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2
Antonietta Coppola, Claudia Cuccurullo, Gianmaria Senerchia, et al.
Epilepsia Open (2024) Vol. 10, Iss. 1, pp. 321-328
Open Access | Times Cited: 1
Successful use of perampanel in GABRA1-related myoclonic epilepsy with photosensitivity
Sara Olivotto, Anna Freddi, Rossella Lavatelli, et al.
Epilepsy & Behavior Reports (2022) Vol. 19, pp. 100544-100544
Open Access | Times Cited: 5
A systematic review of the efficacy of perampanel as treatment for myoclonic seizures and symptomatic myoclonus
Ali Mir, Abdulaziz Alghamdi, Wajd Alotaibi, et al.
Epileptic Disorders (2022) Vol. 24, Iss. 4, pp. 633-646
Closed Access | Times Cited: 5
Efficacy and tolerability of perampanel in a patient with Late-Onset myoclonic epilepsy in Down syndrome (LOMEDS): a case report
Clarissa Corniello, Fedele Dono, Giacomo Evangelista, et al.
Neurological Sciences (2022) Vol. 44, Iss. 2, pp. 757-760
Closed Access | Times Cited: 5
Lafora Disease: A Case Report and Evolving Treatment Advancements
Carola Rita Ferrari Aggradi, M. Rimoldi, Gloria Romagnoli, et al.
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1679-1679
Open Access | Times Cited: 2
Efficacy and tolerability of perampanel: a Chinese real-world observational study in epilepsy
Ya Zeng, Xintong Wu
Frontiers in Neurology (2024) Vol. 14
Open Access
A Reappraisal on cortical myoclonus and brief Remarks on myoclonus of different Origins
Laura Canafoglia, Stefano Meletti, Francesca Bisulli, et al.
Clinical Neurophysiology Practice (2024) Vol. 9, pp. 266-278
Open Access
Response to amoxicillin and perampanel in infantile Alexander disease
Susana Boronat, Eulàlia Turón-Viñas, Noel Mac Manus, et al.
Epilepsia Open (2024)
Open Access
A diagnosis of progressive myoclonic ataxia guided by blood biomarkers: Expert commentary
Luca Pollini, Marina A.J. Tijssen
Parkinsonism & Related Disorders (2021) Vol. 94, pp. 127-128
Open Access | Times Cited: 1
Perampanel

Reactions Weekly (2022) Vol. 1895, Iss. 1, pp. 322-322
Closed Access
A Novel Mutation in Lafora Disease and Update on Pathophysiology and Future Treatments
Douglas R. Nordli, Chethan K. Rao, Antonio V. Delgado‐Escueta, et al.
Child Neurology Open (2022) Vol. 9
Open Access
The Unverricht-Lundborg disease as a part of the progressive myoclonic epilepsies syndrome
Е. Д. Белоусова
Almanac of Clinical Medicine (2022) Vol. 50, Iss. 5, pp. 329-334
Open Access
Page 1

Scroll to top